Public Health

Below please find the Lab's research projects and findings on institutional corruption in the field of public health, in various media.

Blog

New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

by Donald W. Light

Few people know that new prescription drugs have a 1 in 5 chance of causing serious reactions after they have been approved. That is why expert physicians recommend not taking new drugs for at least five years unless patients have first tried better-established options, and have the need to do so.... Read more about New Prescription Drugs: A Major Health Risk With Few Offsetting Advantages

All Public Health Blog Posts
Working Papers
All Public Health Working Papers
Research Projects

The Pharmaceutical Industry, Institutional Corruption, and Public Health

Professor Marc Rodwin’s project grows out of his previous two books on physicians’ conflicts of interest.1 One source of these conflicts of interest is physicians’ financial relationship to pharmaceutical firms. As an Edmond J. Safra Research Lab Fellow, Marc Rodwin is analyzing the legal, financial, and organizational arrangements within which the pharmaceutical industry operates. These sometimes create incentives (for drug firms and their employees) that conflict with the development of knowledge, drug safety, the promotion of public health, and innovation. They also make the public depend inappropriately on pharmaceutical firms to perform certain activities and this leads to institutional corruption. In a series of articles he will analyze the pros and cons of various options for reform.... Read more about The Pharmaceutical Industry, Institutional Corruption, and Public Health

All Public Health Research Projects